S78T (p.Ser78Thr) variant of CD40LG (CD40 ligand)

S78T (p.Ser78Thr) in CD40LG (CD40 ligand) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.14 / 1. The record also includes population frequency data and structural context.

S78T (p.Ser78Thr) variant details